Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Devon C. Hale is active.

Publication


Featured researches published by Devon C. Hale.


Emerging Infectious Diseases | 2009

Illness in long-term travelers visiting GeoSentinel clinics

Lin H. Chen; Mary E. Wilson; Xiaohong M. Davis; Louis Loutan; Eli Schwartz; Jay S. Keystone; Devon C. Hale; Poh Lian Lim; Anne McCarthy; Effrossyni Gkrania-Klotsas; Patricia Schlagenhauf

Length of travel appears to be associated with health risks.


Malaria Journal | 2010

Exploring the relationship between chronic undernutrition and asymptomatic malaria in Ghanaian children.

Benjamin T. Crookston; Stephen C. Alder; Isaac Boakye; Ray M. Merrill; John H Amuasi; Christina A. Porucznik; Joseph B. Stanford; Ty Dickerson; Kirk A. Dearden; Devon C. Hale; Justice Sylverken; Bryce S Snow; Alex Osei-Akoto; Daniel Ansong

BackgroundA moderate association has been found between asymptomatic parasitaemia and undernutrition. However, additional investigation using the gold standard for asymptomatic parasitaemia confirmation, polymerase chain reaction (PCR), is needed to validate this association. Anthropometric measurements and blood samples from children less than five years of age in a rural Ghanaian community were used to determine if an association exists between chronic undernutrition and PCR-confirmed cases of asymptomatic malaria.MethodsThis was a descriptive cross-sectional study of 214 children less than five years of age from a community near Kumasi, Ghana. Blood samples and anthropometric measurements from these children were collected during physical examinations conducted in January 2007 by partners of the Barekuma Collaborative Community Development Programme.ResultsFindings from the logistic model predicting the odds of asymptomatic malaria indicate that children who experienced mild, moderate or severe stunting were not more likely to have asymptomatic malaria than children who were not stunted. Children experiencing anaemia had an increased likelihood (OR = 4.15; 95% CI: 1.92, 8.98) of asymptomatic malaria. Similarly, increased spleen size, which was measured by ultrasound, was also associated with asymptomatic malaria (OR = 2.17; 95% CI: 1.44, 3.28). Fast breathing, sex of the child, and age of the child were not significantly associated with the asymptomatic malaria.ConclusionsNo significant association between chronic undernutrition and presence of asymptomatic malaria was found. Children who experience anaemia and children who have splenomegaly are more likely to present asymptomatic malaria. Programmes aimed at addressing malaria should continue to include nutritional components, especially components that address anaemia.


Clinical Infectious Diseases | 2014

Illness in Travelers Returned From Brazil: The GeoSentinel Experience and Implications for the 2014 FIFA World Cup and the 2016 Summer Olympics

Mary E. Wilson; Lin H. Chen; Pauline Han; Jay S. Keystone; Jakob P. Cramer; Aluisio Cotrim Segurado; Devon C. Hale; Mogens Jensenius; Eli Schwartz; Frank von Sonnenburg; Karin Leder

Common problems in ill returned travelers to Brazil are dermatologic conditions, diarrhea, and febrile illnesses, especially dengue. Knowledge of potential risks can help clinicians to advise travelers attending large events in Brazil and to care for those who become ill.


BMC Infectious Diseases | 2012

Expatriates ill after travel: Results from the Geosentinel Surveillance Network

Poh‐Lian Lim; Pauline Han; Lin H. Chen; Susan MacDonald; Prativa Pandey; Devon C. Hale; Patricia Schlagenhauf; Louis Loutan; Annelies Wilder-Smith; Xiaohong M. Davis; David O. Freedman

BackgroundExpatriates are a distinct population at unique risk for health problems related to their travel exposure.MethodsWe analyzed GeoSentinel data comparing ill returned expatriates with other travelers for demographics, travel characteristics, and proportionate morbidity (PM) for travel-related illness.ResultsOur study included 2,883 expatriates and 11,910 non-expatriates who visited GeoSentinel clinics ill after travel. Expatriates were more likely to be male, do volunteer work, be long-stay travelers (>6 months), and have sought pre-travel advice. Compared to non-expatriates, expatriates returning from Africa had higher proportionate morbidity (PM) for malaria, filariasis, schistosomiasis, and hepatitis E; expatriates from the Asia-Pacific region had higher PM for strongyloidiasis, depression, and anxiety; expatriates returning from Latin America had higher PM for mononucleosis and ingestion-related infections (giardiasis, brucellosis). Expatriates returning from all three regions had higher PM for latent TB, amebiasis, and gastrointestinal infections (other than acute diarrhea) compared to non-expatriates. When the data were stratified by travel reason, business expatriates had higher PM for febrile systemic illness (malaria and dengue) and vaccine-preventable infections (hepatitis A), and volunteer expatriates had higher PM for parasitic infections. Expatriates overall had higher adjusted odds ratios for latent TB and lower odds ratios for acute diarrhea and dermatologic illness.ConclusionsIll returned expatriates differ from other travelers in travel characteristics and proportionate morbidity for specific diseases, based on the region of exposure and travel reason. They are more likely to present with more serious illness.


Clinical Infectious Diseases | 2011

Patterns of Illness in Travelers Visiting Mexico and Central America: The GeoSentinel Experience

Jose Flores-Figueroa; Pablo C. Okhuysen; Frank von Sonnenburg; Herbert L. DuPont; Michael Libman; Jay S. Keystone; Devon C. Hale; Gerd D. Burchard; Pauline V. Han; Annelies Wilder-Smith; David O. Freedman

BACKGROUND Mexico and Central America are important travel destinations for North American and European travelers. There is limited information on regional differences in travel related morbidity. METHODS We describe the morbidity among 4779 ill travelers returned from Mexico and Central America who were evaluated at GeoSentinel network clinics during December 1996 to February 2010. RESULTS The most frequent presenting syndromes included acute and chronic diarrhea, dermatologic diseases, febrile systemic illness, and respiratory disease. A higher proportion of ill travelers from the United States had acute diarrhea, compared with their Canadian and European counterparts (odds ratio, 1.9; P < .0001). During the 2009 H1N1 influenza outbreak from March 2009 through February 2010, the proportionate morbidity (PM) associated with respiratory illnesses in ill travelers increased among those returned from Mexico, compared with prior years (196.0 cases per 1000 ill returned travelers vs 53.7 cases per 1000 ill returned travelers; P < .0001); the PM remained constant in the rest of Central America (57.3 cases per 1000 ill returned travelers). We identified 50 travelers returned from Mexico and Central America who developed influenza, including infection due to 2009 H1N1 strains and influenza-like illness. The overall risk of malaria was low; only 4 cases of malaria were acquired in Mexico (PM, 2.2 cases per 1000 ill returned travelers) in 13 years, compared with 18 from Honduras (PM, 79.6 cases per 1000 ill returned travelers) and 14 from Guatemala (PM, 34.4 cases per 1000 ill returned travelers) during the same period. Plasmodium vivax malaria was the most frequent malaria diagnosis. CONCLUSIONS Travel medicine practitioners advising and treating travelers visiting these regions should dedicate special attention to vaccine-preventable illnesses and should consider the uncommon occurrence of acute hepatitis A, leptospirosis, neurocysticercosis, acute Chagas disease, onchocerciasis, mucocutaneous leishmaniasis, neurocysticercosis, HIV, malaria, and brucellosis.


Emerging Infectious Diseases | 2014

Regional Variation in Travel-related Illness acquired in Africa, March 1997-May 2011

Marc Mendelson; Pauline V. Han; Peter Vincent; Frank von Sonnenburg; Jakob P. Cramer; Louis Loutan; Kevin C. Kain; Philippe Parola; Stefan Hagmann; Effrossyni Gkrania-Klotsas; Mark J. Sotir; Patricia Schlagenhauf; Rahul Anand; Hilmir Asgeirsson; Elizabeth D. Barnett; Sarah Borwein; Gerd D. Burchard; John D. Cahill; Daniel Campion; Francesco Castelli; Eric Caumes; Lin H. Chen; Bradley A. Connor; Christina M. Coyle; Jane Eason; Cécile Ficko; Vanessa Field; David O. Freedman; Abram Goorhuis; Martin P. Grobusch

To understand geographic variation in travel-related illness acquired in distinct African regions, we used the GeoSentinel Surveillance Network database to analyze records for 16,893 ill travelers returning from Africa over a 14-year period. Travelers to northern Africa most commonly reported gastrointestinal illnesses and dog bites. Febrile illnesses were more common in travelers returning from sub-Saharan countries. Eleven travelers died, 9 of malaria; these deaths occurred mainly among male business travelers to sub-Saharan Africa. The profile of illness varied substantially by region: malaria predominated in travelers returning from Central and Western Africa; schistosomiasis, strongyloidiasis, and dengue from Eastern and Western Africa; and loaisis from Central Africa. There were few reports of vaccine-preventable infections, HIV infection, and tuberculosis. Geographic profiling of illness acquired during travel to Africa guides targeted pretravel advice, expedites diagnosis in ill returning travelers, and may influence destination choices in tourism.


Journal of Clinical Microbiology | 2006

Fatal Granulomatous Acanthamoeba Encephalitis Mimicking a Stroke, Diagnosed by Correlation of Results of Sequential Magnetic Resonance Imaging, Biopsy, In Vitro Culture, Immunofluorescence Analysis, and Molecular Analysis

Mehri McKellar; Lahar R. Mehta; John E. Greenlee; Devon C. Hale; Gregory C. Booton; Daryl J. Kelly; Paul A. Fuerst; Rama Sriram; Govinda S. Visvesvara

ABSTRACT Amebic infections involving the central nervous system are rare and difficult to diagnose. Magnetic resonance imaging (MRI) at timed intervals may be helpful, where scans reveal enhancing lesions and increased signal. We report a unique case of granulomatous amebic encephalitis that was proven pathologically with progressive radiological findings on MRI.


Scandinavian Journal of Gastroenterology | 2012

Double-blind placebo-controlled study of mesalamine in post-infective irritable bowel syndrome--a pilot study.

Ashok K. Tuteja; John C. Fang; Manal Al-Suqi; Gregory J. Stoddard; Devon C. Hale

Abstract Objective. Post-infective irritable bowel syndrome (PI-IBS) is characterized by continuing symptoms of irritable bowel syndrome, typically diarrhea-predominant, following an episode of acute gastroenteritis. There is often an increase in sub-epithelial inflammatory and neuroendocrine cells on colonic mucosal biopsy. Mesalamine is an anti-inflammatory agent, effective in the treatment of inflammatory bowel disease. The goal of this study was to compare mesalamine to placebo on symptoms and quality-of-life (QOL) in PI-IBS. Material and methods. Twenty patients who developed diarrhea-predominant IBS after gastroenteritis were randomized to receive mesalamine (Asacol®) 1.6 gm b.i.d. or placebo for 12 weeks in a double-blind placebo-controlled study. QOL was assessed using the IBS-QOL questionnaire. Stool frequency, stool consistency, urgency, severity of abdominal pain, severity of bloating, and global-improvement scale were recorded in daily diaries for 7 days at baseline and every 4 weeks. Data were analyzed by comparing the change from baseline to last follow-up. Results. One patient withdrew after randomization; data were incomplete in two patients. Thus, data were analyzed from 17 patients (11 men and 6 women, median age: 27 years, range 22–45 years). Mesalamine was not associated with significant improvement in global symptoms, abdominal pain, bloating, stool urgency, frequency, or consistency (all p ≥ 0.11) or QOL (p ≥ 0.16). Conclusions. There was no significant improvement in global symptoms or overall QOL with mesalamine in patients with PI-IBS.


Family Practice | 2014

Travel-associated disease among US residents visiting US GeoSentinel clinics after return from international travel

Stefan Hagmann; Pauline V. Han; William M. Stauffer; Andy O. Miller; Bradley A. Connor; Devon C. Hale; Christina M. Coyle; John D. Cahill; Cinzia Marano; Douglas H. Esposito; Phyllis E. Kozarsky

BACKGROUND US residents make 60 million international trips annually. Family practice providers need to be aware of travel-associated diseases affecting this growing mobile population. OBJECTIVE To describe demographics, travel characteristics and clinical diagnoses of US residents who present ill after international travel. METHODS Descriptive analysis of travel-associated morbidity and mortality among US travellers seeking care at 1 of the 22 US practices and clinics participating in the GeoSentinel Global Surveillance Network from January 2000 to December 2012. RESULTS Of the 9624 ill US travellers included in the analysis, 3656 (38%) were tourist travellers, 2379 (25%) missionary/volunteer/research/aid workers (MVRA), 1580 (16%) travellers visiting friends and relatives (VFRs), 1394 (15%) business travellers and 593 (6%) student travellers. Median (interquartile range) travel duration was 20 days (10-60 days). Pre-travel advice was sought by 45%. Hospitalization was required by 7%. Compared with other groups of travellers, ill MVRA travellers returned from longer trips (median duration 61 days), while VFR travellers disproportionately required higher rates of inpatient care (24%) and less frequently had received pre-travel medical advice (20%). Illnesses of the gastrointestinal tract were the most common (58%), followed by systemic febrile illnesses (18%) and dermatologic disorders (17%). Three deaths were reported. Diagnoses varied according to the purpose of travel and region of exposure. CONCLUSIONS Returning ill US international travellers present with a broad spectrum of travel-associated diseases. Destination and reason for travel may help primary health care providers to generate an accurate differential diagnosis for the most common disorders and for those that may be life-threatening.


Diagnostic Microbiology and Infectious Disease | 1995

Evaluation of a commercially available ELISA assay for detection of Giardia lamblia in fecal specimens

William E. Aldeen; Devon C. Hale; Alexander J. Robison; Karen C. Carroll

A total of 417 fecal samples preserved in 10% buffered formalin and PVA were submitted to a commercial microbiology laboratory only for the detection of Giardia lamblia. Results from fecal specimens collected from 411 patients with gastrointestinal symptoms were compared using the following methods: (a) standard Ova & Parasite (O&P) concentration; (b) Alexons ProspecT/Giardia enzyme-linked immunosorbent assay (ELISA) test, and (c) Meridians Direct Fluorescent Antibody (DFA) Stain. In the 29 specimens in which G. lamblia was detected, 10 were O&P, DFA and ELISA positive, 17 were only ELISA positive and two were only Ova & Parasite and Direct Fluorescent Antibody positive. Of the 29 positive specimens, 22 were confirmed as true positives. The ELISA sensitivity was 91% and the specificity was 98%. The expense associated with these methods to detect the presence of Giardia is

Collaboration


Dive into the Devon C. Hale's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Karen C. Carroll

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Xiaohong M. Davis

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge